Answers are grounded in this paper and cite their sources.
Unexpectedly, less than half of patients with WD received treatment recommended in practice guidelines, which may contribute to a high disease burden in terms of hospitalisations, disability and reduced life expectancy. Improving treatment rates, building patient awareness of long-term disease impact or developing a new paradigm of treatment could make a significant contribution to reducing the disease burden.
No takes yet. Share an insight, caveat, or question.
Daniel-Robin et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: